256 related articles for article (PubMed ID: 22864569)
1. Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.
Arabi A; Ullah K; Branca RM; Johansson J; Bandarra D; Haneklaus M; Fu J; Ariës I; Nilsson P; Den Boer ML; Pokrovskaja K; Grandér D; Xiao G; Rocha S; Lehtiö J; Sangfelt O
Nat Commun; 2012; 3():976. PubMed ID: 22864569
[TBL] [Abstract][Full Text] [Related]
2. SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myeloma.
Busino L; Millman SE; Pagano M
Sci Signal; 2012 Dec; 5(253):pt14. PubMed ID: 23211527
[TBL] [Abstract][Full Text] [Related]
3. SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.
Fukushima H; Matsumoto A; Inuzuka H; Zhai B; Lau AW; Wan L; Gao D; Shaik S; Yuan M; Gygi SP; Jimi E; Asara JM; Nakayama K; Nakayama KI; Wei W
Cell Rep; 2012 May; 1(5):434-43. PubMed ID: 22708077
[TBL] [Abstract][Full Text] [Related]
4. BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
Keutgens A; Zhang X; Shostak K; Robert I; Olivier S; Vanderplasschen A; Chapelle JP; Viatour P; Merville MP; Bex F; Gothot A; Chariot A
J Biol Chem; 2010 Aug; 285(33):25831-40. PubMed ID: 20558726
[TBL] [Abstract][Full Text] [Related]
5. The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits.
Fekrmandi F; Wang TT; White JH
Sci Rep; 2015 Aug; 5():13002. PubMed ID: 26269414
[TBL] [Abstract][Full Text] [Related]
6. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
7. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
Kannan MB; Dodard-Friedman I; Blank V
J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
[TBL] [Abstract][Full Text] [Related]
8. Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.
Busino L; Millman SE; Scotto L; Kyratsous CA; Basrur V; O'Connor O; Hoffmann A; Elenitoba-Johnson KS; Pagano M
Nat Cell Biol; 2012 Mar; 14(4):375-85. PubMed ID: 22388891
[TBL] [Abstract][Full Text] [Related]
9. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
[TBL] [Abstract][Full Text] [Related]
10. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
11. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
Zhao D; Zheng HQ; Zhou Z; Chen C
Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
13. A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).
Bialkowska AB; Liu Y; Nandan MO; Yang VW
J Biol Chem; 2014 Feb; 289(9):5997-6005. PubMed ID: 24398687
[TBL] [Abstract][Full Text] [Related]
14. FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.
Suryo Rahmanto A; Savov V; Brunner A; Bolin S; Weishaupt H; Malyukova A; Rosén G; Čančer M; Hutter S; Sundström A; Kawauchi D; Jones DT; Spruck C; Taylor MD; Cho YJ; Pfister SM; Kool M; Korshunov A; Swartling FJ; Sangfelt O
EMBO J; 2016 Oct; 35(20):2192-2212. PubMed ID: 27625374
[TBL] [Abstract][Full Text] [Related]
15. A phosphorylation cascade controls the degradation of active SREBP1.
Bengoechea-Alonso MT; Ericsson J
J Biol Chem; 2009 Feb; 284(9):5885-95. PubMed ID: 19126544
[TBL] [Abstract][Full Text] [Related]
16. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W
Nature; 2011 Mar; 471(7336):104-9. PubMed ID: 21368833
[TBL] [Abstract][Full Text] [Related]
17. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.
Cassavaugh JM; Hale SA; Wellman TL; Howe AK; Wong C; Lounsbury KM
J Cell Biochem; 2011 Dec; 112(12):3882-90. PubMed ID: 21964756
[TBL] [Abstract][Full Text] [Related]
20. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity.
Schülein C; Eilers M; Popov N
FEBS Lett; 2011 Jul; 585(14):2151-7. PubMed ID: 21620836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]